RELMADA THERAPEUTICS INC's ticker is and the CUSIP is 75955J902. A total of 3 filers reported holding RELMADA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,000 | -54.2% | 5,000 | -62.4% | 0.00% | – |
| Q2 2023 | $32,718 | -28.7% | 13,300 | -34.5% | 0.00% | – |
| Q1 2023 | $45,878 | -95.5% | 20,300 | -93.1% | 0.00% | -100.0% |
| Q4 2022 | $1,027,107 | -93.8% | 294,300 | -34.1% | 0.00% | -93.8% |
| Q3 2022 | $16,526,000 | +1434.4% | 446,400 | +687.3% | 0.03% | +1500.0% |
| Q2 2022 | $1,077,000 | -56.1% | 56,700 | -37.6% | 0.00% | 0.0% |
| Q1 2022 | $2,453,000 | +60.9% | 90,900 | +34.3% | 0.00% | +100.0% |
| Q4 2021 | $1,525,000 | -14.2% | 67,700 | -0.1% | 0.00% | -50.0% |
| Q3 2021 | $1,777,000 | +945.3% | 67,800 | +1179.2% | 0.00% | – |
| Q2 2021 | $170,000 | -43.9% | 5,300 | -38.4% | 0.00% | – |
| Q1 2021 | $303,000 | -5.6% | 8,600 | -14.0% | 0.00% | -100.0% |
| Q4 2020 | $321,000 | -30.1% | 10,000 | -18.0% | 0.00% | 0.0% |
| Q3 2020 | $459,000 | +691.4% | 12,200 | +838.5% | 0.00% | – |
| Q2 2020 | $58,000 | +1833.3% | 1,300 | +1200.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 67,800 | $1,777,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10,400 | $349,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |